跳至主要内容
临床试验/EUCTR2021-002247-30-FR
EUCTR2021-002247-30-FR进行中(未招募)1 期

Evaluation of Amoxicillin diffusion in breast milk according to a population pharmacokinetic approach. - CONCEPTION-AMOX

CHU TOULOUSE0 个研究点目标入组 25 人开始时间: 2021年7月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Mothers over 18, treated with Amoxicillin for at least 2 days, breastfeeding their child and living in an area covered by the authorization of one of the ethics committees concerned by this multicenter study will be eligible for the study,
  • -Participation requires that breastfeeding has been started for at least 2 weeks after childbirth and that the infant is more than 4 weeks old,
  • -Affiliation to the social security scheme or equivalent,
  • -Ability to understand and willingness to sign a written informed consent document for withdrawal of plasma and milk.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Mothers under 18 years old,
  • -Infants born prematurely (i.e. gestational age of less than 34 weeks) or requiring appropriate medical supervision or the support of a team of social workers,
  • -Mothers who have given birth to twins,
  • -Inability to communicate with mother due to language problems,
  • -Patient subject to a legal protection order (curatorship or tutorship)

研究者

发起方
CHU TOULOUSE

相似试验